ArticleInternational journal of molecular sciences2026
Comprehensive Prediction Analysis of Novel Noncoding Regulatory Variants Identified in the MicroRNA Binding Regions in Complement System Genes.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The complement system is a central component of innate immunity that coordinates host defense, immune surveillance, and inflammatory responses through tightly regulated proteolytic cascades. Genetic variation within complement genes contributes substantially to interindividual differences in complement activity and disease susceptibility. While coding variants directly alter complement protein structure and function, the microRNA (miRNA)-mediated control and post-transcriptional regulation is not fully understood in shaping complement gene expression across immune and inflammatory mechanisms. Complement pathway genes exhibit extensive and heterogeneous 3'-untranslated regions (3'UTRs), which serve as primary platforms for miRNA binding and RNA-binding protein interactions. Both common and rare single-nucleotide polymorphisms within coding regions and 3'UTRs can influence miRNA targeting efficiency, disrupt regulatory motifs, or alter mRNA turnover, thereby fine-tuning complement activity rather than causing complete loss of function. Here, we systematically analyzed miRNA binding sites and single-nucleotide polymorphisms (SNPs) within the 3'UTRs of complement pathway genes spanning the classical, lectin, alternative, and terminal pathways. Our analysis uncovered heterogeneous patterns of miRNA-mediated regulation across the complement system. While core complement components showed relatively sparse conserved miRNA targeting, regulatory factors, receptors, and terminal pathway proteins emerged as densely regulated nodes, harboring multiple conserved binding sites. A broad repertoire of miRNAs was predicted to engage complement genes in a pathway-specific manner, implicating these interactions in inflammation, cancer progression, metabolic regulation, and immune signaling. SNPs within miRNA-binding regions are predicted to disrupt or create regulatory interactions, providing a mechanistic basis for how non-coding genetic variation can alter gene expression and modulate disease susceptibility. Our findings indicate miRNA-mediated post-transcriptional regulation as an important yet underappreciated layer of complement system control, providing a framework for understanding how regulatory genetic variation shapes complement-driven immune responses and disease risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.